PTC Therapeutics | PTCT - EPS Earnings Per Share


PTC Therapeutics reported $-0.03 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.03 -0.43 10.04 May/07
FY2025Q4 Dec/2025 -1.67 -0.47 -0.85 Feb/19
FY2025Q3 Sep/2025 0.20 -1.02 -1.39 Nov/04
FY2025Q2 Jun/2025 -0.83 -1.07 -1.29 Aug/07
FY2025Q1 Mar/2025 10.04 -1.35 -1.20 May/06




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
TG Therapeutics USD 0.12 0.02 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Xencor USD -1.71 1.62 Mar/2026